Skip to content

Therapac, Inc.

Country not established

Devices
1

What Therapac, Inc. makes

Therapac, Inc. manufactures HEMOGASTAT, a medical device designed for hemostasis (stopping bleeding) in surgical and trauma settings.

The HEMOGASTAT is classified as a Class I device under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Hemogastat Ref K801148

    Active Regimes: 510(k) Registry: 510(k) Class:I

Frequently asked questions

How many devices does Therapac, Inc. have in the registry?

The registry currently lists 1 device for Therapac, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Therapac, Inc.'s devices?

Among its 1 most recently registered device, Therapac, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Therapac, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Therapac, Inc.'s devices are Class I. Each device page shows its own class and authorisation.

What are the newest devices from Therapac, Inc. in the registry?

The most recently registered devices listed for Therapac, Inc. include HEMOGASTAT.

Generated automatically from registry data and not verified by a human reviewer.